CV Lattes
Universidade São Francisco (USF). Campus Bragança Paulista (Institutional affiliation for the last research proposal) Birthplace: Brazil
Bachelor in Biomedicine with specialization in Clinical Pathology and Molecular Biology from São Francisco University - USF (Campus of Bragança Paulista). Student of Scientific Initiation, with experience in the area of Histology, Cellular and Molecular Biology. Attended one year (August/2014 - July/2015) as a volunteer, and one year (August/2015 - July/2016) as PIBIC/CNPq Scholar, under the guidance of Professor Dr. Thalita Rocha, acting on the following theme: The relations between obesity and the central nervous system (CNS). Recently attended one year (August/2016 - April/2017) as PIBIC/CNPq Scholar and one year (May/2017 - December/2017) as FAPESP Scholar under the guidance of Professor Dr. Manoela Marques Ortega, working on the following theme: Identification and characterization of single nucleotide polymorphisms in genes and microRNAs involved in tumorigenesis. Master degree in in Health Science, with emphasis on Cellular and Molecular Biology, by the Post-Graduation Program - Strictu Sensu at São Francisco University - USF (Campus of Bragança Paulista) as CAPES Scholar (March/2018 - July/2018) and FAPESP Scholar (August/2018 - February/2020) under the guidance of Professor Dr. Manoela Marques Ortega. Specialist in Clinical Pharmacy in Oncology by the Post-Graduation Program - Lato Sensu at Braz Cubas University - UBC (EAD). Currently is a PhD student in Health Science, with an emphasis on Cellular and Molecular Biology, at the Post-Graduation Program - Stricto Sensu at São Francisco University - USF (Campus de Bragança Paulista) as a BDC Scholar (August/2020) under the guidance of Profa. Dra. Manoela Marques Ortega. Worked as Clinical Analyst at the Integrated Unit of Pharmacology and Gastroenterology - UNIFAG (July/2020 - November/2021), being responsible for carrying out the exams for molecular diagnosis for COVID-19. Also worked as Junior Research and Development Analyst at Vyttra Diagnósticos, being responsible for the validation of Point of Care (PoC) tests (January/2022 - July/2022). (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Glioblastoma multiforme (GBM) accounts for 15-20% of neurological tumors and being considered the most aggressive. Biological heterogeneity and resistance to chemotherapy are the major obstacles facing the development of effective treatment for GBM. Several genes and signaling pathways have been identified to be responsible for the aggressive phenotype of this tumor. The NF-ºB pathway is …
Glioblastoma multiforme (GBM) represents about 15-20% of neurological tumors and considered the most aggressive. Biological heterogeneity and resistance to chemotherapy are the largest obstacles to effective treatment of GBM. Several genes and signaling pathways were identified to be responsible for the aggressive phenotype of this tumor; one is the NF-ºB signaling pathway. In mammals, ar…
| 2 / 2 | Completed scholarships in Brazil |
| Associated processes | |